{
  "trial_id": "NCT00773279",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, type of diabetes (Type 1 or Type 2), duration of diabetes, body mass index (BMI), HbA1c levels, current insulin regimen, use of oral anti-diabetic medication, history of hypoglycemia, history of diabetic ketoacidosis, presence of comorbidities (e.g., cardiovascular disease, gastrointestinal disease, neurological disease), previous participation in clinical trials, alcohol or drug use history, mental capacity, and language proficiency.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "HbA1c (glycosylated haemoglobin)",
          "HbA1c levels"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "type of diabetes (Type 1 or Type 2)",
        "duration of diabetes",
        "body mass index (BMI)",
        "current insulin regimen",
        "use of oral anti-diabetic medication",
        "history of hypoglycemia",
        "history of diabetic ketoacidosis",
        "presence of comorbidities (e.g., cardiovascular disease, gastrointestinal disease, neurological disease)",
        "previous participation in clinical trials",
        "alcohol or drug use history",
        "mental capacity",
        "language proficiency"
      ]
    },
    "processed-gen-response": "Age, sex, type of diabetes (Type 1 or Type 2), duration of diabetes, body mass index (BMI), HbA1c levels, current insulin regimen, use of oral anti-diabetic medication, history of hypoglycemia, history of diabetic ketoacidosis, presence of comorbidities (e.g., cardiovascular disease, gastrointestinal disease, neurological disease), previous participation in clinical trials, alcohol or drug use history, mental capacity, and language proficiency."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type of Diabetes (Type 1 or Type 2), Duration of Diabetes, Body Mass Index, Baseline HbA1c, Daily Insulin Dose, Use of Oral Anti-diabetic Medication,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HbA1c (glycosylated haemoglobin)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Type of Diabetes (Type 1 or Type 2)",
        "Duration of Diabetes",
        "Body Mass Index",
        "Daily Insulin Dose",
        "Use of Oral Anti-diabetic Medication"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Type of Diabetes (Type 1 or Type 2), Duration of Diabetes, Body Mass Index, Baseline HbA1c, Daily Insulin Dose, Use of Oral Anti-diabetic Medication"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Type, Diabetes Duration, Body Mass Index, HbA1c, Insulin Dose, Insulin Regimen, Region of Enrollment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HbA1c (glycosylated haemoglobin)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Diabetes Type",
        "Diabetes Duration",
        "Body Mass Index",
        "Insulin Dose",
        "Insulin Regimen"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Type, Diabetes Duration, Body Mass Index, HbA1c, Insulin Dose, Insulin Regimen, Region of Enrollment."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, BMI, duration of diabetes, type of diabetes, HbA1c at screening, insulin dose and regimen at baseline, oral anti-diabetic medication use, history of hypoglycaemia, history of diabetic ketoacidosis, cardiovascular disease history, smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "HbA1c (glycosylated haemoglobin)",
          "HbA1c at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "BMI",
        "duration of diabetes",
        "type of diabetes",
        "insulin dose and regimen at baseline",
        "oral anti-diabetic medication use",
        "history of hypoglycaemia",
        "history of diabetic ketoacidosis",
        "cardiovascular disease history",
        "smoking status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, BMI, duration of diabetes, type of diabetes, HbA1c at screening, insulin dose and regimen at baseline, oral anti-diabetic medication use, history of hypoglycaemia, history of diabetic ketoacidosis, cardiovascular disease history, smoking status."
  }
}